News Corporate

WERFEN TO DIVEST MEDICAL DEVICES AND SCIENTIFIC INSTRUMENTATION DISTRIBUTION BUSINESSES TO PALEX

Werfen signs an agreement with Palex to divest its Medical Devices and Scientific Instrumentation Distribution businesses in Spain and Portugal.

April 15, 2024 - Barcelona, Spain

Venta

 

PRESS RELEASE

Werfen to sell Medical Devices and Scientific Instrumentation Distribution businesses to Palex 

  • Werfen signs an agreement with Palex to divest its Medical Devices and Scientific Instrumentation Distribution businesses in Spain and Portugal.

  • The transaction is expected to be completed in the third quarter of this year.

On March 20, 2024 Werfen announced an agreement to sell its Medical Devices and Scientific Instrumentation Distribution businesses in Spain and Portugal to Palex for more than €100 million. The transaction is subject to customary regulatory approvals and is expected to be completed in the third quarter of this year.

The sale includes Izasa Medical, Izasa Scientific, and MC Medical. Together, these companies represented 7% of Werfen’s total sales in 2023. In recent years, the company’s strategic focus has evolved significantly, influenced by various factors such as market dynamics, strategic opportunities, and shifts in the industry landscape. This divestiture will enable Werfen to focus on specialized diagnostics, its core business. For Palex, the acquisition is an opportunity to continue offering its customers innovative solutions of the highest quality.

“These businesses are deeply rooted in our company's history and, through the years, have become renowned in Spain and Portugal,” said Werfen CEO Carlos Pascual. “I am especially pleased that in Palex, we have found an owner able to provide our employees with an opportunity to join a company that will focus on growing these businesses.”

Commenting on their prospective acquisition, Palex CEO Xavier Carbonell said, “At Palex, we are thrilled about this acquisition, as it allows us to reinforce our position as the premier Pan-European platform in Medical Devices and Life Sciences. I am confident that the integration between both parties will be very smooth and natural, thanks to the significant convergence of philosophy and values.” 

 

Werfen

Founded in 1966, Werfen is a developer, manufacturer, and worldwide distributor of specialized diagnostic instruments, related reagents, automation work cells, and data management solutions for use primarily in hospitals and independent clinical laboratories. The company's business lines include Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, Transplant, and Original Equipment Manufacturing (OEM). Werfen operates directly in more than 30 countries and more than 100 territories through distributors. For more information, visit werfen.com 

 

Palex

Palex is the benchmark provider of advanced solutions for healthcare professionals in the hospital, laboratory, and research fields. Founded in 1955, with a clear innovative vocation, it is a leader in supplying equipment to the hospital sector in Southern Europe (Spain, Portugal and Italy). With a team of over 800 people, Palex provides healthcare professionals with the most cutting-edge and innovative tools in the market so they can perform their work to the best of their ability, thus providing patients with the best diagnosis and treatment possible. 

 

Press Contact 

OmniCom PR Group

Ana Gonzalez, Associate Director

+ 34 609129735

 

Legal notice 

This document contains forward-looking statements about our business, financial data, and events related to the prospects of Werfen. These forecasts can be identified by the use of words such as “expectation”, “vision”, “anticipation”, “intention”, “plan”, “belief”, “search”, “estimate”, “future”, “project”, or words with a similar meaning. We may also make projections in other reports, presentations, and press releases. Furthermore, our sales representatives may occasionally make forward-looking statements. These projections are based on our current expectations and on certain hypotheses, many of which are beyond the corporation’s control and subject to a series of risks and uncertainties. In the event that any of these risks or uncertainties should materialize or the underlying expectations are not fulfilled, the results or performance of Werfen may differ substantially (either positively or negatively) from those explicitly or implicitly forecast. Werfen assumes no obligation to update or revise any forward-looking statements made previously. 

Share Press Release:

LinkedIn twitter facebook
Contact us

We are unable to answer any questions related to invoices, quotes, and product information through this channel.

Click here to select your country for relevant contact information.

DATA PROTECTION POLICY:

Werfen, S.A. will process your personal data to respond to your requests for information or support, or to understand your needs and provide you with a better service relying on our legitimate interest to do so. You can find more information about our data privacy practices and how to exercise your rights in our Privacy Policy. You can also contact us at DPO@werfen.com.